Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
USANA HEALTH SCIENCES INC
Bear Case (25th pct.)
29.3% vs price
Base Case (Median)
50.8% vs price
Bull Case (75th pct.)
110.5% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $18.20 | 25.4% | High (40%) |
| EV/EBITDA | $47.74 | 228.8% | Medium (20%) |
| EV/FCF | $24.84 | 71.0% | Medium (20%) |
| Earnings Power Value | $18.96 | 30.6% | Medium (50%) |
Based on 4 out of 7 methods, USNA appears undervalued at the current price of $14.52. The base case fair value of $21.90 implies 50.8% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.